Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG
Background Facing the ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is an urgent need for serological assays identifying individuals with past coronavirus disease 2019 (COVID-19). Study design Our study is the first to compare four new commercially av...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12474
- Acceso en línea:
- https://www.sciencedirect.com/science/article/pii/S1386653220301360?via%3Dihub
http://hdl.handle.net/20.500.12010/12474
https://doi.org/10.1016/j.jcv.2020.104394
- Palabra clave:
- COVID-19
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
ELISA
SARS-CoV-2
- Rights
- License
- Acceso restringido